Somatotroph is one of those subjects where the details matter more than the headlines. This page pulls together the background, the mechanisms, and the practical points readers ask about most.
Last reviewed on 2025-10-24. Where a claim depends on a specific study, the study is described rather than over-claimed.
Clinical interest in tesamorelin arose from the need to address visceral adiposity in people living with HIV. Antiretroviral therapy improved survival but was associated in some patients with central fat accumulation, altered lipid profiles, and metabolic complications. This condition, often called HIV-associated lipodystrophy, involves excess visceral adipose tissue that is difficult to manage through diet and exercise alone. Investigators evaluated tesamorelin because GHRH analogs can stimulate growth hormone secretion and influence fat distribution without direct liposuction or invasive procedures.
A Phase 3 program led to regulatory approval in the United States in 2010 for reduction of excess visceral abdominal fat in adults with HIV and lipodystrophy. Subsequent studies examined effects on liver fat, muscle area, and metabolic markers, with mixed findings for some endpoints. Long-term cardiovascular outcomes and effects on mortality remain uncertain because most trials were relatively short and focused on imaging-based fat measurements. Use in populations without HIV has been studied experimentally but is not part of the approved indication.
Tesamorelin is a synthetic analog of growth hormone-releasing hormone, a peptide hormone produced by the hypothalamus. The molecule retains the 44-amino-acid sequence of human GHRH and carries a trans-3-hexenoyl modification at its N-terminus. This modification increases resistance to enzymatic degradation and extends the peptide's functional stability relative to native GHRH. The compound is supplied as a lyophilized powder for reconstitution and subcutaneous administration in clinical settings. Its development code was TH9507, and it belongs to the GHRH analog class. It is not a growth hormone product; instead, it acts upstream to stimulate endogenous growth hormone release.
Tesamorelin is a synthetic peptide that acts as an analog of growth hormone-releasing hormone, a natural hypothalamic signal. Its sequence corresponds to the forty-four amino acid form of the human hormone, with a small acyl group attached near the amino terminus. That modification slows enzymatic breakdown and extends the time the peptide remains active in circulation. The compound was developed as a pharmacological way to raise endogenous growth hormone output rather than supplying the hormone directly.
After injection, the peptide binds receptors on somatotroph cells in the anterior pituitary. Receptor activation raises intracellular cyclic AMP and triggers release of stored growth hormone into the bloodstream. Because the compound works through the body's own regulatory system, growth hormone pulses retain much of their normal feedback control. Repeated administration also raises insulin-like growth factor 1, a hormone produced mainly in the liver. Investigators treat that rise as a marker that the pituitary axis has been engaged.
| Property | Value | Notes |
|---|---|---|
| Molecular weight | Approximately 5,136 Da | Based on the 44-amino-acid peptide backbone and N-terminal modification. |
| Appearance | White to off-white lyophilized powder | Usually supplied in single-use vials for reconstitution. |
| Solubility | Freely soluble in water; slightly soluble in some organic solvents | Peptide nature supports aqueous reconstitution. |
| Typical storage | 2–8 °C, protected from light | Refrigeration reduces degradation; avoid freezing unless specified. |
| Common analytical method | Reverse-phase high-performance liquid chromatography | Used for identity, purity, and quantification. |
| Synonyms | Tesamorelin, TH9507, GHRH(1-44) analog | Generic descriptors; avoid proprietary names. |
tesamorelin 是一种人工合成的四十四肽，序列与内源性生长激素释放激素（GHRH）的 1-44 片段一致，区别在于 N 端加接了一个反式-3-己烯酰基。该修饰抑制二肽基肽酶 IV 的快速切割，从而延长分子在循环中的存留时间。作为肽类分子，它难以经胃肠道吸收，文献中讨论的均是注射途径。分类上通常把它归为 GHRH 类似物，以区别于生长激素本身。
作用位置在垂体前叶。tesamorelin 与 GHRH 受体结合后激活腺苷酸环化酶，升高细胞内 cAMP，再经蛋白激酶 A 通路促进生长激素的合成与释放。由于它作用于内源调控节点，生长激素仍以脉冲方式分泌，而不是被持续抬升到固定水平。生长激素随后在肝脏等组织诱导胰岛素样生长因子 1 产生，构成完整的生长激素轴响应。
研究背景集中在特定人群的体成分改变，尤其是与脂肪分布异常相关的内脏脂肪堆积。不同地区对它的监管状态与获批适应症并不一致，部分市场仅限特定诊断人群使用。在一般人群中的长期效应、与其他激素的相互作用以及停药后的维持情况仍属开放问题，现有数据不足以给出普遍结论。
HCO2H → H2 + CO2 Soluble ruthenium catalysts are also effective for producing carbon monoxide-free hydrogen. It is used as a source of hydrogen in transfer hydrogenation, as in the Leuckart reaction to make amines and (in aqueous solution or in its azeotrope with triethylamine) for hydrogenation of ketones.
== Techniques in genome sequencing for pseudouridine == Pseudouridine can be identified through a multitude of different techniques. A common technique to identify modifications in RNA and DNA is Liquid Chromatography with Mass Spectrometry or LC-MS. Mass spectrometry separates molecules by the mass and charge. While uridine and pseudouridine have the same mass, they have different charges. Liquid chromatography works by retention time, which has to do with leaving the column. A chemical way to identify pseudouridine uses a compound called CMC or N-cyclohexyl-N′-β-(4-methylmorpholinium) ethylcarbodiimide to specifically label and distinguish uridine from pseudouridine. CMC will bond both with pseudouridine and uridine, but holds tighter to the former, because of the third nitrogen able to form hydrogen bond. CMC bound to pseudouridine can then be imaged by tagging a signaling molecule. This method is still being worked on to become high-throughput. An improved technique, 2-bromoacrylamide-assisted cyclization sequencing, enables Ψ-to-C transitions, for quantitative profiling of Ψ at single-base resolution.
represents body accelerations acting on the continuum, for example gravity, inertial accelerations, electrostatic accelerations, and so on. In this form, it is apparent that in the assumption of an inviscid fluid – no deviatoric stress – Cauchy equations reduce to the Euler equations. Assuming conservation of mass, with the known properties of divergence and gradient we can use the mass continuity equation, which represents the mass per unit volume of a homogenous fluid with respect to space and time (i.e., material derivative
Sources: en.wikipedia.org
Hong Kong is home to a wide range of museums, galleries, and cultural institutions, and is regarded as one of Asia's leading centres for art, heritage, and visual culture. Major cultural development in the city has taken place in the West Kowloon Cultural District, a large arts and museum quarter on reclaimed land in Kowloon. Its best-known institutions include M+, a museum of visual culture focused on 20th and 21st century art, design, architecture, and moving image, and the Hong Kong Palace Museum, which displays Chinese artworks and artifacts. Apart from West Kowloon, Hong Kong has many additional museums across the territory. The Hong Kong Museum of Art in Tsim Sha Tsui houses collections of Chinese antiquities, calligraphy, painting, and Hong Kong art. The Hong Kong Heritage Museum in Sha Tin focuses on history, art, and local popular culture, with exhibitions on Cantonese opera, film, and design. The Hong Kong Museum of History presents the development of Hong Kong from prehistoric times to the present, while the Hong Kong Science Museum and Hong Kong Space Museum are among the city's main public institutions devoted to science and education. Tai Kwun, a former police station and prison compound in Central, has been revitalised as a centre for heritage and contemporary art, and hosts exhibitions, performances, and public programmes.
Ineffective erythropoiesis (red blood cell production) can lead to expansion of the bone marrow in compensation; this can then lead to deformity, bone pain, and craniofacial abnormalities. Organs such as the liver and spleen that can also become enrolled in red blood cell production, leading to hepatosplenomegaly (enlargement of the liver and spleen). People with thalassemia can get too much iron in their bodies, either from the disease itself as RBCs are destroyed, or as a consequence of frequent blood transfusions. Excess iron is not excreted, but forms toxic non-transferrin-bound iron. This can lead to organ damage, potentially affecting the heart, liver, endocrine system, bones and spleen. Symptoms include an irregular heartbeat, cardiomyopathy, cirrhosis of the liver, hypothyroidism, delayed puberty and fertility problems, brittle and deformed bones, and an enlarged spleen. For clinical purposes, thalassemia is categorised as either transfusion-dependent thalassemia (TDT) or non-transfusion-dependent thalassemia (NTDT) are used. Patients are usually considered as having NTDT if they have received fewer than 6 red blood cell units in the past 6 months and none in the preceding 2 months.
5' cap Also five-prime cap. A specially altered nucleotide attached to the 5'-end of some primary RNA transcripts as part of the set of post-transcriptional modifications which convert raw transcripts into mature RNA products. The precise structure of the 5' cap varies widely by organism; in eukaryotes, the most basic cap consists of a methylated guanine nucleoside bonded to the triphosphate group that terminates the 5'-end of an RNA sequence. Among other functions, capping helps to regulate the export of mature RNAs from the nucleus, prevent their degradation by exonucleases, and promote translation in the cytoplasm. Mature mRNAs can also be decapped.
Sources: en.wikipedia.org
Various strategies have been employed for constraining α-helices, including the non-covalent and covalent stabilization techniques; however, the all-hydrocarbon covalent link, termed a peptide staple, has been shown to have improved stability and cell penetrability, making this stabilization strategy particularly relevant for clinical applications.
=== Impact of pregnancy === During pregnancy, the ovaries and the placenta produce estrogen and progesterone. These hormones stimulate the 15 to 20 lobes of the milk-secreting glands in the breasts to develop. Women who experience multiple pregnancies repeatedly stretch the skin envelope during engorgement while lactating. As a woman's breasts change in size during repeated pregnancies, the size of her breasts change as her mammary glands are engorged with milk and as she gains and loses weight with each pregnancy. In addition, when milk production stops (usually as a child is weaned), the voluminous mammary glands diminish in volume, but they still add bulk and firmness to the breast. A 2010 review found that weight gain during pregnancy and breastfeeding were not significant risk factors for ptosis.
Peter S. Tippett (born 1953) is an American physician, researcher, and inventor known for contributions to information security, clinical medicine, and technology. These contributions include the development of the anti-virus program "Corporate Vaccine." Tippett was Vice President of Verizon's Innovations Incubator and Chief Medical Officer for Verizon Enterprise Services from 2009 to 2015. He is currently the Founder and CEO of careMESH Inc.
== Guest characters == Fragrantian Erika (フラグラント星人 衛里香, Furanguranto Seijin Erika): The princess of a royal intergalactic family from Planet Fragrant. She is kidnapped by Kevakia, who attempts to ransom her for the rare-but-powerful Wellness Stone, but she is rescued by Ban and Hoji, who delete Kevakia. Erika is portrayed by Risa Yoshiki (吉木 りさ, Yoshiki Risa). Doltockian Mano Mark (ドルトック星人マノ・マーク, Dorutokku Seijin Mano Māku): A scientist from Planet Doltock who attempts to deal with Beildon under the alias of Iwaki (岩木), only to be arrested for abetting the Alienizer's crimes. His human form is portrayed by Minosuke (みのすけ). Juuzaian Braidy (ジューザ星人ブライディ, Jūza Seijin Buraidi): A mantis-themed alien from Planet Juuza whom Kersus framed for the murder of her sister Karmia and Agent Abrella enlarged to distract the Dekarangers, who discover the truth and arrest Braidy for causing property damage in his enlarged state. Braidy is voiced by Yūsuke Numata (沼田 祐介, Numata Yūsuke). Hikaru Hiwatari (日渡 氷狩, Hiwatari Hikaru): A young ESPer with the ability to teleport inanimate objects. Originally a street wanderer, he hated humans because they mistreated him due to his powers, and he wanted to leave the planet as soon as possible. An Alienizer named Dazgonelr uses this to manipulate Hikaru into helping him commit crimes, until Jasmine convinces Hikaru to trust her. Following Dazgonelr's deletion, Hikaru leaves Earth to join S.P.D.'s training academy.
Sources: en.wikipedia.org
It is a synthetic peptide analog of human growth hormone-releasing hormone. It is used clinically to reduce excess visceral abdominal fat in adults with HIV-associated lipodystrophy. It works by stimulating pituitary growth hormone release.
Pivotal trials enrolled adults with HIV and excess visceral abdominal fat, often in the context of antiretroviral therapy. Participants were assessed mainly by computed tomography for visceral adipose tissue. The approved indication remains specific to that population.
Long-term effects on cardiovascular events, mortality, and sustained fat distribution are not well established. Most trials measured changes over months rather than years. Open questions also include whether benefits persist after treatment stops.
It is a laboratory-made peptide that mimics growth hormone-releasing hormone. It prompts the pituitary gland to release growth hormone and has been studied mainly in adults with HIV-associated lipodystrophy.